Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Anagrelide
Active substance: anagrelide
Indication: Thromboreductin (anagrelide) is indicated for the reduction of an increased platelet number and associated clinical symptoms in high risk patients with essential thrombocythemia
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2014 PSUSA - Modification EMEA/H/C/PSUSA/208/201309 (2014)6804 of 18/09/2014